Patients with hepatitis B teratitis B have the potential to develop liver cancer at a later stage. Hepatitis B triple positive patients are infected with hepatitis B virus, and chronic viral hepatitis is one of the more common causes of liver cancer. Some studies have found that hepatitis B virus surface antigen-positive people are 25 to 37 times more likely to develop liver cancer than uninfected people. Hepatitis B triple positive patients have long-term active inflammation in the liver, which is an important cause of liver cancer. Clinical manifestations may include nausea, vomiting, epigastric discomfort, jaundice and impaired liver function. It is recommended that patients with hepatitis B teratitis III be regularly screened for hepatitis B two halves, hepatitis B DNA quantification and abdominal ultrasound under the guidance of doctors. When the value of hepatitis B DNA is high, antiviral treatment should be carried out in time. At the same time, avoiding staying up late, overworking and eating more fresh vegetables can help reduce the possibility of liver cell cancer.